MALARIA,FALCIPARUM
Clinical trials for MALARIA,FALCIPARUM explained in plain language.
Never miss a new study
Get alerted when new MALARIA,FALCIPARUM trials appear
Sign up with your email to follow new studies for MALARIA,FALCIPARUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New malaria pill shows promise in early trial
Disease control Not yet recruitingThis study tests a new oral drug, GSK3772701, in 70 adults with uncomplicated malaria caused by P. falciparum. The goal is to find safe and effective doses and treatment lengths. Participants will take the drug for a short time and be monitored for side effects and how well the d…
Matched conditions: MALARIA,FALCIPARUM
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New combo strategy aims to boost malaria protection for african children
Prevention Not yet recruitingThis study in Uganda will test whether giving children both the R21 malaria vaccine and two new types of malaria prevention pills works better than the vaccine alone. About 1,290 children will take part. The goal is to see if the combination can reduce cases of symptomatic malari…
Matched conditions: MALARIA,FALCIPARUM
Phase: PHASE4 • Sponsor: Stanford University • Aim: Prevention
Last updated May 22, 2026 13:52 UTC
-
New malaria shot could offer months of protection
Prevention Not yet recruitingThis study tests a new long-acting injection called MMV371 to see if it can safely prevent malaria. About 80 healthy people aged 12 to 50 in Rwanda will get either the study drug or a placebo. Researchers will check for side effects and measure drug levels in the body over 24 wee…
Matched conditions: MALARIA,FALCIPARUM
Phase: PHASE1 • Sponsor: Medicines for Malaria Venture • Aim: Prevention
Last updated May 20, 2026 11:53 UTC